Skip to main content
Premium Trial:

Request an Annual Quote

EXCLUSIVE: GenomicFX to Close its Doors in August

NEW YORK, July 25 – GenomicFX, an animal genomics company based in Austin, Tex., will close its doors in August, GenomeWeb learned Wednesday.

Company officials did not respond to calls. Gerard Davis, the CEO of Genetic Solutions, a Brisbane, Australia-based company that GenomicFX acquired in February, referred a reporter to GenomicFX. GenomicFX’s website contained only a link to Genetic Solutions.

In February, GenomicFX announced that it had licensed Incyte's LifeSeq Gold and Zooseq databases, and that Incyte would provide custom sequencing services to help build GenomicFX’s proprietary databases of cattle and swine genomic information. At the time, GenomicFX said it would create animal blood tests to help livestock breeders select animals for high quality meat production capabilities, as well as develop an identification tool to verify the breed or origin of a cut of meat. 

Genometrix, a provider of custom-designed and prefabricated microarrays, SNP genotyping services, and software tools based in The Woodlands, Tex., ceased operations on June 25.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.